No name

Did you know that schizophrenia affects more than 1 percent of the world's population? See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

Schizohrenia research & FAQs


Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

NARSAD Young Investigator Grantee Bo Li, Ph.D. of Cold Spring Harbor Laboratory, Expert on PTSD
Bo Li, Ph.D.
January 31, 2013

A pair of small almond-shaped structures called the amygdalae are often said to be the human brain’s “fear centers.” Many experiments have shown their involvement in the fear response—a complex series of biological...

Brain & Behavior Research Foundation Scientific Council Member, Susan G. Amara, Ph.D.
Susan G. Amara, Ph.D.
January 29, 2013

Internationally-recognized neurobiologist and Brain & Behavior Research Foundation Scientific Council Member, Susan G. Amara, Ph.D., was recently appointed to the prestigious position of Scientific Director for the...

NARSAD Young Investigator Grantee Dr. Rupert Lanzenberger and colleagues at the Medical University of Vienna, in Austria expert on depression
Dr. Rupert Lanzenberger
January 28, 2013

Electroconvulsive therapy (ECT) has been used successfully for 70 years to relieve symptoms of major depression. Remarkably, though, precise details about how it acts on the brain to produce this effect was unknown—until...

Brain & Behavior Research Foundation 2010 NARSAD Young Investigator Grantee Frederick C. Nucifora, Jr., Ph.D., D.O., M.H.S.
Dr. Frederick C. Nucifora, Jr.
January 25, 2013

Researchers led by Brain & Behavior Research Foundation 2010 NARSAD Young Investigator Grantee Frederick C. Nucifora, Jr., Ph.D., D.O., M.H.S. have identified a rare gene mutation in a family with a high rate of...

Brain & Behavior Research Foundation NARSAD Distinguished Investigator Grant, Akira Sawa, M.D., Ph.D. and Johns Hopkins University, schizophrenia and depression
Akira Sawa, M.D., Ph.D.
January 21, 2013

With support from a 2011 Brain & Behavior Research Foundation NARSAD Distinguished Investigator Grant, Akira Sawa, M.D., Ph.D. and Johns Hopkins University colleagues have shown that when mice with a genetic...

Pages

Subscribe to